Although the medtech industry is expected to enjoy steady growth, device companies are still challenged to attract the skilled labor that manufacturing requires.
The agency is allowing the emergency use of a CDC 2019-nCoV real-time PCR panel.
FDA, CDC and other agencies are trying to foster the development of diagnostics, therapeutics and vaccines that help address the outbreak.
The state’s attorney general said J&J put its profits “ahead of the health of millions of women”.
The latest regulations for human and veterinary medicinal products, as well as medical devices, include the mandate to set up databases with detailed information about available products. These databases must be realized and implemented in the near future, and require a concerted effort now if tangible real-world benefits are to follow.
Analysts expect 2020 to be a busy year for M&A activity.
The safety communication notes that patients being monitored via GE’s Healthcare Clinical Information Central Stations and Telemetry Services could be at risk.
A discussion of the changing medtech markets and how companies can remain cognizant of potentially disruptive changes in their business and industry for future success in their product portfolios, services and relationships.
The outlook for 2020 and beyond is positive, but medical device companies must continue to evolve their technologies and partnerships to keep the attention of investors.
Special controls are also provided for reasonable assurance of the safety and effectiveness of the devices impacted by the reclassification.